These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3014535)

  • 1. Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase.
    Maul GG; French BT; van Venrooij WJ; Jimenez SA
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5145-9. PubMed ID: 3014535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications of centromere movement during interphase and differentiation.
    Manuelidis L
    Ann N Y Acad Sci; 1985; 450():205-21. PubMed ID: 3860180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to topoisomerase I in sera from patients with scleroderma.
    Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I.
    Guldner HH; Szostecki C; Vosberg HP; Lakomek HJ; Penner E; Bautz FA
    Chromosoma; 1986; 94(2):132-8. PubMed ID: 2428564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining the Scl-70 indirect immunofluorescence pattern: autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern.
    Dellavance A; Gallindo C; Soares MG; da Silva NP; Mortara RA; Andrade LE
    Rheumatology (Oxford); 2009 Jun; 48(6):632-7. PubMed ID: 19395540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.
    Meyer KN; Kjeldsen E; Straub T; Knudsen BR; Hickson ID; Kikuchi A; Kreipe H; Boege F
    J Cell Biol; 1997 Feb; 136(4):775-88. PubMed ID: 9049244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphoid satellite DNA is tightly associated with centromere antigens in human chromosomes throughout the cell cycle.
    Masumoto H; Sugimoto K; Okazaki T
    Exp Cell Res; 1989 Mar; 181(1):181-96. PubMed ID: 2917601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies from a patient with scleroderma CREST recognized kinetochores of the higher plant Haemanthus.
    Mole-Bajer J; Bajer AS; Zinkowski RP; Balczon RD; Brinkley BR
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3599-603. PubMed ID: 2185478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centromere proteins. I. Mitosis specific centromere antigen recognized by anti-centromere autoantibodies.
    Hadlaczky G; Praznovszky T; Rasko I; Kereso J
    Chromosoma; 1989 Jan; 97(4):282-8. PubMed ID: 2651051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant DNA topoisomerase I is recognized and inhibited by human Scl-70 sera autoantibodies.
    Agris PF; Parks R; Bowman L; Guenther RH; Kovacs SA; Pelsue S
    Exp Cell Res; 1990 Aug; 189(2):276-9. PubMed ID: 2164485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients.
    Brenner S; Pepper D; Berns MW; Tan E; Brinkley BR
    J Cell Biol; 1981 Oct; 91(1):95-102. PubMed ID: 7298727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of topoisomerase I by antibodies in sera from scleroderma patients.
    Samuels DS; Tojo T; Homma M; Shimizu N
    FEBS Lett; 1986 Dec; 209(2):231-4. PubMed ID: 2431927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients.
    Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
    Science; 1986 Feb; 231(4739):737-40. PubMed ID: 3003910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II is a structural component of mitotic chromosome scaffolds.
    Earnshaw WC; Halligan B; Cooke CA; Heck MM; Liu LF
    J Cell Biol; 1985 May; 100(5):1706-15. PubMed ID: 2985625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centromere autoantigens are associated with the nucleolus.
    Ochs RL; Press RI
    Exp Cell Res; 1992 Jun; 200(2):339-50. PubMed ID: 1572401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody to centromere (kinetochore) in scleroderma sera.
    Moroi Y; Peebles C; Fritzler MJ; Steigerwald J; Tan EM
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1627-31. PubMed ID: 6966403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection of anticentromere antibodies in interphase disrupts events required for chromosome movement at mitosis.
    Bernat RL; Borisy GG; Rothfield NF; Earnshaw WC
    J Cell Biol; 1990 Oct; 111(4):1519-33. PubMed ID: 2211824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.
    Kallenberg CG
    Clin Rev Allergy; 1994; 12(3):221-35. PubMed ID: 7804956
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
    Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
    Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus.
    Tsay GJ; Fann RH; Hwang J
    J Rheumatol; 1990 Oct; 17(10):1314-9. PubMed ID: 2174971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.